INCB186748
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INCB186748, covering 2026-03-23 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation [Phase 1]